>
Switch to:

PTC Therapeutics E10

: $-5.27 (As of Mar. 2022)
View and export this data going back to 2013. Start your Free Trial

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PTC Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2022 was $-1.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.27 for the trailing ten years ended in Mar. 2022.

As of today (2022-05-21), PTC Therapeutics's current stock price is $32.33. PTC Therapeutics's E10 for the quarter that ended in Mar. 2022 was $-5.27. PTC Therapeutics's Shiller PE Ratio of today is .


PTC Therapeutics E10 Historical Data

The historical data trend for PTC Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PTC Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -4.99

PTC Therapeutics Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
E10 Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -4.83 -4.99 -5.27

Competitive Comparison

For the Biotechnology subindustry, PTC Therapeutics's E10, along with its competitors' market caps and E10 data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

PTC Therapeutics E10 Distribution

For the Biotechnology industry and Healthcare sector, PTC Therapeutics's E10 distribution charts can be found below:

* The bar in red indicates where PTC Therapeutics's E10 falls into.



PTC Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PTC Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2022 (Change)*Current CPI (Mar. 2022)
=-1.78/121.3010*121.3010
=-1.780

Current CPI (Mar. 2022) = 121.3010.

PTC Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201206 0.022 96.819 0.028
201209 -0.514 97.633 -0.639
201212 0.008 96.871 0.010
201303 -1.248 98.209 -1.541
201306 -5.510 98.518 -6.784
201309 -0.190 98.790 -0.233
201312 -0.751 98.326 -0.926
201403 -0.580 99.695 -0.706
201406 -0.860 100.560 -1.037
201409 -0.930 100.428 -1.123
201412 -0.840 99.070 -1.028
201503 -1.150 99.621 -1.400
201506 -1.140 100.684 -1.373
201509 -1.270 100.392 -1.535
201512 -1.500 99.792 -1.823
201603 -1.220 100.470 -1.473
201606 -1.140 101.688 -1.360
201609 -1.030 101.861 -1.227
201612 -0.780 101.863 -0.929
201703 -0.850 102.862 -1.002
201706 -0.440 103.349 -0.516
201709 -0.820 104.136 -0.955
201712 0.030 104.011 0.035
201803 -0.460 105.290 -0.530
201806 -0.210 106.317 -0.240
201809 -1.060 106.507 -1.207
201812 -0.960 105.998 -1.099
201903 -1.290 107.251 -1.459
201906 -0.750 108.070 -0.842
201909 -1.060 108.329 -1.187
201912 -1.370 108.420 -1.533
202003 -1.810 108.902 -2.016
202006 -2.780 108.767 -3.100
202009 -1.030 109.815 -1.138
202012 -1.050 109.897 -1.159
202103 -1.830 111.754 -1.986
202106 -1.680 114.631 -1.778
202109 -1.890 115.734 -1.981
202112 -2.030 117.630 -2.093
202203 -1.780 121.301 -1.780

Add all the adjusted EPS together and divide 10 will get our e10.


PTC Therapeutics  (NAS:PTCT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PTC Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of PTC Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


PTC Therapeutics Business Description

PTC Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
100 Corporate Court, South Plainfield, NJ, USA, 07080
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Executives
Southwell David P director C/O INOTEK PHARMACEUTICALS CORPORATION 91 HARTWELL AVENUE LEXINGTON MA 02421
Jacobson Allan Steven director PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Peltz Stuart Walter director, officer: Chief Executive Officer PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Utter Christine Marie officer: SVP, Finance & CAO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Boulding Mark Elliott officer: Exec. VP and CLO C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Hill Emily Luisa officer: Chief Financial Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Svoronos Dawn director C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Pauwels Eric officer: Chief Business Officer 550 HILLS DRIVE BEDMINSTER NJ 07921
Klein Matthew B. officer: Chief Development Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Schmertzler Michael director 1300 VALLEY ROAD NEW CANAAN CT 06840
Souza Marcio officer: Chief Operating Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Almstead Neil Gregory officer: Chief Technical Ops Officer C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Reeve Emma director C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Steele Glenn Jr Md Phd director 250 TECHNOLOGY PARK LAKE MARY FL 32746-6232
Zeldis Jerome B director 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258

PTC Therapeutics Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)